CRISIL Upgrades Tatva Chintan Pharma Chem's Credit Ratings
Tatva Chintan Pharma Chem Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 10:47 pm
CRISIL Upgrades Tatva Chintan Pharma Chem's Credit Ratings CRISIL Ratings upgraded Tatva Chintan Pharma Chem Limited鈥檚 credit ratings on 8th Sep'26 across Rs 245 crore total bank loan facilities. Long-term bank facilities were upgraded to CRISIL A-/Stable from CRISIL BBB+/Stable, while short-term facilities were upgraded to CRISIL A2+ from CRISIL A2. The rated debt profile comprises Rs 220 crore in fund-based limits, Rs 10.5 crore in letter of credit and bank guarantees, alongside a Rs 14.5 crore proposed term loan. The upgrade reflects strengthened creditworthiness and improved financial risk metrics.
Original exchange filing (PDF)
More announcements from Tatva Chintan Pharma Chem Ltd
- Updated Investor Presentation. 路 20 Oct 2026
- Investor Presentation for the quarter and half year ended 30 September 2026. 路 19 Oct 2026
- Earnings Call scheduled to be held on Monday, 19 October 2026 at 05:00 p.m. (IST) has been cancelled due to unforeseen circumstances. 路 19 Oct 2026
- Outcome Of the Board Meeting Held On 19.10.2026 路 19 Oct 2026
- Enclosed 路 19 Oct 2026
- Tatva Chintan Pharma Chem Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 19 Oct 2026
- Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 路 16 Oct 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of .... 路 19 Oct 2026
